Loading organizations...
AI-powered proteomics platform developer measuring biological age and organ health for longevity, focused on extending healthspan.
Based in Glasgow, Scotland, Entourage AI develops AI-powered proteomics platforms designed to measure biological age and assess organ health. The company utilizes mass spectrometry to analyze thousands of proteins across individuals aged 16 to 85, generating personalized precision medicine insights aimed at extending healthspan and preventing diseases such as cancer and cardiovascular conditions. Its core consumer products, which include the Aging Clock, Organ Health, and AI Coach, are currently available for pre-order as the firm targets both individual users and future integration with global healthcare providers like the NHS. To support its research and operations, the enterprise recently secured $5 million in pre-seed funding led by Provision, with additional participation from GU Holdings Ltd, David Peterson, and Brad Peltz. Operating as a spin-out from the University of Glasgow, Entourage AI was founded in 2026 by Patrick T. Gunning.
Entourage AI has raised $501.0M across 1 funding round.
Entourage AI has raised $501.0M in total across 1 funding round.
Entourage AI has raised $501.0M in total across 1 funding round.
Entourage AI's investors include Provision, Brad Peltz, David Peterson, University of Glasgow.
Entourage AI has raised $501.0M across 1 funding round. Most recently, it raised $501.0M Pre-Seed in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 18, 2026 | $501.0M Pre-Seed | Provision | Brad Peltz, David Peterson, University of Glasgow |